Rock Springs Capital Management LP Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$3.9B
Holdings
148
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (148 positions)
| Stock | Value |
|---|---|
IRTCIRHYTHM TECHNOLOGIES INC | $148.8M |
NBIXNEUROCRINE BIOSCIENCES INC | $140.9M |
—IMMUNOMEDICS INC | $135.0M |
UNHUNITEDHEALTH GROUP INC | $126.3M |
HUMHUMANA INC | $100.4M |
2L9BLUEPRINT MEDICINES CORP | $88.3M |
ISRGINTUITIVE SURGICAL INC | $85.1M |
CNCCENTENE CORP DEL | $77.0M |
ARGXARGENX SE | $75.5M |
PODDINSULET CORP | $74.6M |
ZLABZAI LAB LTD | $68.5M |
NVTA1EURINVITAE CORP | $65.8M |
ACADACADIA PHARMACEUTICALS INC | $64.9M |
NVV1NOVAVAX INC | $63.5M |
HCAHCA HEALTHCARE INC | $62.3M |
ONCBEIGENE LTD | $61.6M |
PCRXPACIRA BIOSCIENCES | $60.4M |
MRTXEURMIRATI THERAPEUTICS INC | $57.9M |
FRPTFRESHPET INC | $56.6M |
AGIOAGIOS PHARMACEUTICALS INC | $55.4M |
NVROEURNEVRO CORP | $53.8M |
BAXBAXTER INTL INC | $51.9M |
HZNPHORIZON THERAPEUTICS PUB L | $50.5M |
ALNYALNYLAM PHARMACEUTICALS INC | $49.5M |
IDXXIDEXX LABS INC | $49.1M |
BIIBBIOGEN INC | $48.9M |
SGENEURSEATTLE GENETICS INC | $48.9M |
SRPTSAREPTA THERAPEUTICS INC | $48.5M |
RAREULTRAGENYX PHARMACEUTICAL IN | $47.4M |
AFWALIGN TECHNOLOGY INC | $46.8M |
EWEDWARDS LIFESCIENCES CORP | $46.5M |
EHCENCOMPASS HEALTH CORP | $45.4M |
TFXTELEFLEX INCORPORATED | $44.3M |
EXASEXACT SCIENCES CORP | $43.2M |
BSXBOSTON SCIENTIFIC CORP | $42.0M |
ASNDASCENDIS PHARMA A/S | $36.0M |
—MERSANA THERAPEUTICS INC | $35.1M |
PENPENUMBRA INC | $30.9M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $30.9M |
CHRSCOHERUS BIOSCIENCES INC | $30.5M |
INSPINSPIRE MED SYS INC | $30.5M |
—EPIZYME INC | $30.4M |
MDGLMADRIGAL PHARMACEUTICALS INC | $30.2M |
CVETUSDCOVETRUS INC | $29.9M |
INCYINCYTE CORP | $26.9M |
ARDXARDELYX INC | $26.7M |
BMRNBIOMARIN PHARMACEUTICAL INC | $26.6M |
IMVTIMMUNOVANT INC | $26.1M |
ALXNALEXION PHARMACEUTICALS INC | $25.7M |
HCATHEALTH CATALYST INC | $25.7M |
PHRPHREESIA INC | $25.7M |
MIRMMIRUM PHARMACEUTICALS INC | $25.6M |
BFAMBRIGHT HORIZONS FAM SOL IN D | $25.2M |
GLPGGALAPAGOS NV | $24.8M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $24.5M |
ASMBASSEMBLY BIOSCIENCES INC | $24.1M |
INZYINOZYME PHARMA INC | $23.1M |
KYMRKYMERA THERAPEUTICS INC | $22.9M |
ACHCACADIA HEALTHCARE COMPANY IN | $22.4M |
GHGUARDANT HEALTH INC | $21.2M |
—MOMENTA PHARMACEUTICALS INC | $21.0M |
APLTAPPLIED THERAPEUTICS INC | $20.6M |
RPRXROYALTY PHARMA PLC | $20.4M |
ATHAATHIRA PHARMA INC | $20.4M |
ALLKGUSDALLAKOS INC | $19.7M |
NVCRNOVOCURE LTD | $19.5M |
—PPD INC | $19.4M |
—RETROPHIN INC | $18.9M |
KRTXKARUNA THERAPEUTICS INC | $18.9M |
HQYHEALTHEQUITY INC | $18.5M |
CGENCOMPUGEN LTD | $18.4M |
AMRNAMARIN CORP PLC | $18.3M |
TGTXTG THERAPEUTICS INC | $18.3M |
CYTK 4 11/15/26CYTOKINETICS INC | $17.8M |
RLAYRELAY THERAPEUTICS INC | $17.6M |
SWAVUSDSHOCKWAVE MED INC | $16.7M |
NKTXNKARTA INC | $16.3M |
GOSS 5 06/01/27GOSSAMER BIO INC | $16.0M |
OSH3EUROAK STR HEALTH INC | $16.0M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $15.9M |
QUREUNIQURE NV | $15.2M |
AM6AMICUS THERAPEUTICS INC | $14.5M |
CNMDCONMED CORP | $14.2M |
SPROSPERO THERAPEUTICS INC | $13.8M |
AKROAKERO THERAPEUTICS INC | $13.0M |
FGENEURFIBROGEN INC | $12.7M |
ACCDEURACCOLADE INC | $12.6M |
APREAPREA THERAPEUTICS INC | $12.5M |
TBPHTHERAVANCE BIOPHARMA INC | $12.2M |
—GW PHARMACEUTICALS PLC | $11.6M |
FUSNFUSION PHARMACEUTICALS INC | $11.4M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $11.4M |
AUPHAURINIA PHARMACEUTICALS INC | $11.4M |
ARVNARVINAS INC | $11.4M |
OSWONESPAWORLD HOLDINGS LIMITED | $11.3M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $11.3M |
TREURTRILLIUM THERAPEUTICS INC | $11.0M |
PRLDPRELUDE THERAPEUTICS INC | $10.9M |
TARAPROTARA THERAPEUTICS INC | $10.8M |
—CONSTELLATION PHARMCETICLS I | $10.4M |
Page 1 of 2Next